298 related articles for article (PubMed ID: 35682549)
1. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.
Ahmed EA; Rajendran P; Scherthan H
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682549
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
3. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
4. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/β-catenin.
Li S; Wu T; Zhang D; Sun X; Zhang X
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):703-712. PubMed ID: 31854468
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608.
Miao Z; Guo X; Tian L
Gene; 2019 Mar; 687():116-124. PubMed ID: 30453063
[TBL] [Abstract][Full Text] [Related]
9. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM
Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-452: a double-edged sword in multiple human cancers.
Karimi Dermani F; Datta I; Gholamzadeh Khoei S
Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
12. The function of miR-145 in colorectal cancer progression; an updated review on related signaling pathways.
Mozammel N; Amini M; Baradaran B; Mahdavi SZB; Hosseini SS; Mokhtarzadeh A
Pathol Res Pract; 2023 Feb; 242():154290. PubMed ID: 36621158
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M; Mirdamadi MSA; Talebi Y; Khaniabad N; Banaei G; Daneii P; Gholami S; Ghorbani A; Tavakolpournegari A; Farsani ZM; Zarrabi A; Nabavi N; Zandieh MA; Rashidi M; Taheriazam A; Entezari M; Khan H
Pharmacol Res; 2023 Jan; 187():106568. PubMed ID: 36423787
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin.
Liao Z; Li Y; Zhou Y; Huang Q; Dong J
Mol Med Rep; 2018 Jan; 17(1):602-611. PubMed ID: 29115517
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.
Yang J; Fan B; Zhao Y; Fang J
Oncol Rep; 2017 Sep; 38(3):1670-1678. PubMed ID: 28714009
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway.
Zhu B; Chen H; Zhang X; Pan Y; Jing R; Shen L; Wang X; Ju S; Jin C; Cong H
Int J Oncol; 2018 Nov; 53(5):2131-2144. PubMed ID: 30132507
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
